Synapse - Hematologic Malignancies Service

Search Within

Hematologic Malignancies Service

Results (612)

Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia

Journal Article

Almeida, A.; T'Sas, S.; Pagliaro, L.; Fijalkowski, I.; Sleeckx, W.; Van Steenberge, H.; Zamponi, R.; Lintermans, B.; Van Loocke, W.; Palhais, B.; more...
HemaSphere (2024)

Fulltext@MSK | Save

Osteopetrorickets: Two contradictory patterns—one unifying diagnosis

Journal Article

Behr, G.; Kuhn, M.; Oved, J. H.; Sulis, M. L.
Skeletal Radiology (2024)

Fulltext@MSK | Save

A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML

Journal Article

Dao, T.; Xiong, G.; Mun, S. S.; Meyerberg, J.; Korontsvit, T.; Xiang, J.; Cui, Z.; Chang, A. Y.; Jarvis, C.; Cai, W.; more...
Blood (2024)

Fulltext@MSK | Save

POE14-01: A phase I study of carfilzomib in combination with cyclophosphamide and etoposide for children, adolescents and young adults with relapsed/refractory leukemias or solid tumors

Meeting Abstract

Boklan, J.; Narendran, A.; Bielamowicz, K.; Trippett, T.; Brown, V.; Dubois, S.; Eshun, F.; Gelfond, J.; Zomet, A.; Lacayo, N.; more...
Pediatric Blood and Cancer (2023)

Fulltext@MSK | Save

Anti-leukemic activity of Luveltamab tazevibulin (LT, STRO-002), a novel Folate receptor-α (FR-α)-targeting antibody drug conjugate (ADC) in relapsed/refractory CBF2AT3::GLIS2 AML

Meeting Abstract

Williams, R.; Miller, L.; Massaro, S.; Krieger, E.; Pauly, M.; Nelson, C.; Johnson, R.; Welch, J. J. G.; Bhojwani, D.; Moghimi, B.; more...
Blood (2023)

Fulltext@MSK | Save

Revumenib monotherapy in patients with relapsed/refractory KMT2Ar acute leukemias: Efficacy and safety results from the AUGMENT-101 phase 1/2 study

Meeting Abstract

Aldoss, I.; Issa, G. C.; Thirman, M. J.; DiPersio, J.; Arellano, M.; Blachly, J. S.; Mannis, G.; Perl, A.; Dickens, D.; McMahon, C. M.; more...
Blood (2023)

Fulltext@MSK | Save

A de novo supernumerary ring chromosome 1 causes B-cell acute lymphoblastic leukemia in monozygotic twins due to independent and partially convergent evolutionary trajectories

Meeting Abstract

Gutiérrez-Abril, J.; Gundem, G.; Fiala, E.; Liosis, K.; Farnoud, N.; Leongamornlert, D.; Amallraja, A.; Ossa, J. E. A.; Domenico, D.; Levine, M. F.; more...
Blood (2023)

Fulltext@MSK | Save

Progression-free survival (PFS) and toxicity with nivolumab-AVD compared to brentuximab vedotin-AVD in pediatric advanced stage (AS) classic Hodgkin lymphoma (cHL), results of SWOG S1826

Meeting Abstract

Castellino, S. M.; Li, H.; Herrera, A. F.; Punnett, A.; Leblanc, M.; Parsons, S. K.; Hodgson, D.; Keller, F.; Drachtman, R. A.; Lamble, A.; more...
Blood (2023)

Fulltext@MSK | Save

Results from an intergroup randomized phase II study of the combinations of ipilimumab, nivolumab and brentuximab vedotin in patients with relapsed/refractory classic Hodgkin lymphoma: A trial of the ECOG-ACRIN Research Group (E4412)

Meeting Abstract

Diefenbach, C. S.; Jegede, O.; Ansell, S. M.; Steidl, C.; Natkunam, Y.; Scott, D. W.; Mehta-Shah, N.; Amengual, J. E.; Forlenza, C. J.; Cole, P. D.; more...
Blood (2023)

Fulltext@MSK | Save

Preliminary safety and efficacy of venetoclax and selinexor in combination with chemotherapy in pediatric and young adult patients with relapsed or refractory acute myeloid leukemia: SELCLAX

Meeting Abstract

Zarnegar-Lumley, S.; Karol, S. E.; Pounds, S.; Klco, J. M.; Sulis, M. L.; Kuo, D. J.; Heym, K. M.; Ludwig, K.; Stevens, A. M.; Alexander, T. B.; more...
Blood (2023)

Fulltext@MSK | Save